GlassScriptPhysician profile
Mary D Wells
NPI 1487612966
$6,680.25
in general payments reported to CMS, 2019-2025
50 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $303 · 2021: $1,361 · 2022: $665 · 2023: $1,019 · 2024: $1,317 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,381.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,110.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,289.82 | 2019-2025 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Allergan, INC. | $393.76 | 2019-2021 | |
| Novo Nordisk INC | $320.33 | 2019-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $284.28 | 2019-2025 | |
| Astellas Pharma US INC | $259.84 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $240.15 | 2021-2025 | Phexxi, Solosec, Phexx |
| Takeda Pharmaceuticals U.S.A., INC. | $231.12 | 2019-2024 | Trintellix |
| Sumitomo Pharma America, INC. | $207.44 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $176.30 | 2023-2025 | |
| Galderma Laboratories, L.P. | $150.45 | 2022-2025 | Dysport |
| Sage Therapeutics, LLC | $138.36 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $124.85 | 2019-2023 | Mara Console |
| Mylan Pharmaceuticals INC. | $124.28 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $124.09 | 2019-2022 | |
| Therapeuticsmd, INC. | $120.05 | 2019-2022 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $106.48 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $104.64 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $102.68 | 2019-2025 | Aptima |
| Davol INC. | $87.85 | 2021 | |
| Myovant Sciences INC. | $86.72 | 2021-2022 | |
| Organon LLC | $86.45 | 2022-2025 | Nexplanon |
| Roche Diagnostics Corporation | $71.29 | 2019-2021 | |
| Boston Scientific Corporation | $68.59 | 2019-2022 | |
| Axsome Therapeutics, INC. | $68.18 | 2023-2025 | Auvelity |
| Duchesnay USA Incorporated | $54.12 | 2019 | |
| Glaxosmithkline, LLC. | $52.24 | 2021-2023 | Bexsero |
| Channel Medsystems, INC. | $46.70 | 2024-2025 | |
| Nalpropion Pharmaceuticals LLC | $41.10 | 2019 | |
| Meditrina | $40.07 | 2022-2023 | |
| Avion Pharmaceuticals | $35.06 | 2022 | |
| Pfizer INC. | $34.30 | 2023-2024 | |
| Daiichi Sankyo INC. | $33.22 | 2019 | |
| Lilly USA, LLC | $33.01 | 2024 | Zepbound, Jardiance |
| Millicent US INC | $32.56 | 2024-2025 | Femring, Intrarosa |
| Biom'Up France Sas | $32.35 | 2021 | |
| Exact Sciences Corporation | $31.41 | 2025 | The Cologuard Plus Collection Kit |
| Vivus LLC | $29.41 | 2019-2020 | |
| Coloplast Corp | $27.59 | 2019-2021 | |
| Intuitive Surgical, INC. | $25.00 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $20.68 | 2023 | Vivjoa |
| Vertex Pharmaceuticals Incorporated | $17.25 | 2025 | |
| Bausch Health US, LLC | $15.62 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.08 | 2019 | |
| Covidien LP | $14.66 | 2019 | |
| Merck Sharp & Dohme LLC | $14.63 | 2019 | |
| Axonics, INC. | $14.52 | 2024 | Axonics |
| Agile Therapeutics, INC. | $13.97 | 2024 | Twirla |
| Shire North American Group INC | $13.40 | 2019 | |
| Amgen INC. | $12.59 | 2019 | |
| Lupin INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.